Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing Effects of RO5545965 for schizophrenia.
Multiple locations, including Garden GroveThis study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.
Multiple locations, including PhoenixThis study is completed. It is testing Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, for Bipolarity.
Location not clearly listedThis study is completed in the United States, in Bulgaria, in Malaysia, .... It is testing ALKS 9072 (Also Known for schizophrenia.
Multiple locations, including Little RockThis study is completed in the United States. It is testing armodafinil Treatment for depression.
Multiple locations, including BirminghamThis study is completed in the United States. It is testing dasotraline for ADHD.
Multiple locations, including Newport BeachThis study is completed in the United States. It is testing dasotraline for ADHD.
Multiple locations, including Newport BeachThis study is completed in the United States. It is testing ENX-102 for anxiety.
Multiple locations, including PhoenixThis study is completed in the United States, in Greece, in Lithuania, .... It is testing Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity.
Multiple locations, including CerritosThis study is completed in China. It is testing intramuscular Levosulpiride for schizophrenia.
Multiple locations, including BaodingThis study is completed in the United States, in France, in Bulgaria, .... It is testing JNJ-42847922 for depression.
Multiple locations, including AnaheimThis study is completed in the United States. It is testing NBI-1070770 for depression.
Multiple locations, including Little RockHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.